more details about the commercial arrangements going down the track would be good, but perhaps they are not worked out as yet- $1 m seem lousy to get it started really, and is merely a cratch of a few skin cells to AstraZeneca
- it is to be assumed the executives here are just not giving the technology away for peanuts ( though most likely are!)
Ann: AstraZeneca Partners LBT for APAS Pharma Development, page-7
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LBT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $22.89M | |||
| Open | High | Low | Value | Volume |
| 1.6¢ | 1.7¢ | 1.6¢ | $19.94K | 1.200M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1080146 | 1.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.7¢ | 292624 | 1 |
View Market Depth
| Last trade - 16.10pm 25/06/2024 (20 minute delay) ? |
| LBT (ASX) Chart |